Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, SARS-CoV-2 test
Clinical narrative: Lost all smell for about 10 weeks; Lost all taste for about 10 weeks; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 14-Feb-2022 and was forwarded to Moderna on 14-Feb-2022.    This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (Lost all smell for about 10 weeks) and AGEUSIA (Lost all taste for about 10 weeks) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C214A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic.   In 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced ANOSMIA (Lost all smell for about 10 weeks) and AGEUSIA (Lost all taste for about 10 weeks). At the time of the report, ANOSMIA (Lost all smell for about 10 weeks) and AGEUSIA (Lost all taste for about 10 weeks) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Rapid COVID test came back negative.         Concomitant information was not provided.  Patient received both his Moderna vaccines earlier in 2021 and had no problems. After he received the booster he lost all smell and taste for about 10 weeks. However, patient further stated that in the past month everything had been perfect, and his smell and taste are back.  Treatment information was not provided.  Company Comment: This spontaneous case concerns a 79 year old male with no relevant medical history reported, who experienced non-serious , unexpected, AESI event of Ageusia and anosmia which occurred on an unknown date after vaccination with the third dose of mRNA-1273 vaccine ( this patient reported he also received mRNA-1273 vaccine for the primary series vaccine with no reported adverse events ) .  The events were reported to have lasted  for 10 week  and presently has resolved. There were no reports of any medical consult and  work-up done  or if any  treatment was  given The benefit -risk relationship of mRNA -1273 ( Moderna Covid 19 Vaccine) is not affected by this report.; Sender's Comments: This spontaneous case concerns a 79 year old male with no relevant medical history reported, who experienced non-serious , unexpected, AESI event of Ageusia and anosmia which occurred on an unknown date after vaccination with the third dose of mRNA-1273 vaccine ( this patient reported he also received mRNA-1273 vaccine for the primary series vaccine with no reported adverse events ) .  The events were reported to have lasted  for 10 week  and presently has resolved. There were no reports of any medical consult and  work-up done  or if any  treatment was  given The benefit -risk relationship of mRNA -1273 ( Moderna Covid 19 Vaccine) is not affected by this report.